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Placental up-regulation of free fetal haemoglobin (fHbF) occurs in preeclamptic (PE) pregnancy. Heme
oxygenase-1 (HO-1) is an important vasculoprotective enzyme in the catabolism of the associated
heme porphyrin structure.We have previously shown that fHbF negatively influences the vasculopro-
tective capacity of the fetal circulation. Herewe study fHbF levels in the fetal cord blood of pregnancies
complicated by PE; a pathology associatedwith dysregulated fetoplacental vascular tone.Wehave pre-
viously shown that fHbF binds nitric oxide (NO) to elicit elevated vascular resistance in the fetoplacen-
tal circulation, using ex vivo human dual placental perfusion and in vitro placental endothelial cell shear
stress studies. Furthermore, fHbF causes morphological changes to the fetoplacental endothelium.
Here we hypothesise that elevated levels of fHbF in fetal plasma associated with placental pathology
contribute to fetoplacental hypertension. Purpose: To evaluate and derive a robust cord blood
collection and processing protocol for the accurate measurement of fetal plasma fHbF levels in
normal and PE pregnancies.
Methods: Fetal venous cord blood was collected by syringe and needle, or Vacutainer method into
either EDTA or citrate tubes, within 10 minutes of partum. Plasma recovery occurred immediately,
or after 30 minutes, prior to centrifugation at 2000g x 10 min at room temperature. Following evalu-
ation to reduce mechanical haemolysis, newly collected normal & PE plasma (n=13 & 6, respectively)
was subjected to ELISAs for HbF and HO-1. Results: Venipuncture collection of cord venous blood
taken from the cord-placenta insertion point by Vacutainer systemwith a 21G needle, into citrate col-
lection tubeswith immediate centrifugationpreventedmechanical haemolysis. Therewasnodifference
in plasma HO-1 between groups (medians = 5.9 & 5.3 ng/mL; normal & PE, respectively;
Mann-Whitney). Whilst there was no difference in fHbF between groups (Mann-Whitney), variability
was high in the PE group and therewere some very high values for fHbF compared to the normal range,
whilst fHbF values in the control group were within a tighter lower range (medians & ranges = 45.9 &
0-206 and 118.8 & 29-640 mg/mL).
Conclusion: Fetal plasma HO-1 levels appear stable in preeclamptic fetal plasma, permitting fHbF to
remain unchecked in some cases. High pathophysiological levels of fHbF in some cases of PE pregnan-
cies are capable of evoking elevated vascular resistance within the fetoplacental circulation, caused by
nitric oxide sequestration and disruption to the endothelium. Further evaluation is required.
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